Gilead Sciences (GILD) Current Assets (2009 - 2026)
Gilead Sciences posted quarterly Current Assets of $18.6 billion for Q1 2026, up 10.3% year-on-year from $16.9 billion in Q1 2025, and up 1.63% on a QoQ basis from $18.3 billion in Q4 2025.
Gilead Sciences (GILD) has 18 years of Current Assets data on file, last reported at $18.6 billion in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 10.3% year-over-year to $18.6 billion; the trailing twelve-month figure through Mar 2026 stood at $18.6 billion (up 10.3% YoY), and the FY2025 full-year result was $18.3 billion, down 4.33% from the prior year.
- Current Assets for Q1 2026 stood at $18.6 billion, up from $18.3 billion in the prior quarter.
- Across five years, Current Assets topped out at $19.2 billion in Q4 2024 and bottomed at $12.3 billion in Q2 2024.
- The 5-year median for Current Assets is $14.7 billion (2025), against an average of $15.3 billion.
- The widest annual swing landed in 2024, when Current Assets fell 13.79%; it then gained 20.94% in 2025.
- A 5-year view of Current Assets shows it stood at $14.4 billion in 2022, then gained by 11.37% to $16.1 billion in 2023, then advanced by 19.2% to $19.2 billion in 2024, then fell by 4.33% to $18.3 billion in 2025, then increased by 1.63% to $18.6 billion in 2026.
- The last three Current Assets figures came in at $18.6 billion (Q1 2026), $18.3 billion (Q4 2025), and $17.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 54.84 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 59.17 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 33.53 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 35.02 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 31.48 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 18.64 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 42.82 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 27.21 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 23.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.64 Bn |
| Dec 31, 2025 | 18.34 Bn |
| Sep 30, 2025 | 17.87 Bn |
| Jun 30, 2025 | 14.72 Bn |
| Mar 31, 2025 | 16.90 Bn |
| Dec 31, 2024 | 19.17 Bn |
| Sep 30, 2024 | 14.78 Bn |
| Jun 30, 2024 | 12.32 Bn |
| Mar 31, 2024 | 14.04 Bn |
| Dec 31, 2023 | 16.09 Bn |
| Sep 30, 2023 | 15.98 Bn |
| Jun 30, 2023 | 14.29 Bn |
| Mar 31, 2023 | 13.46 Bn |
| Dec 31, 2022 | 14.44 Bn |
| Sep 30, 2022 | 13.55 Bn |
| Jun 30, 2022 | 13.18 Bn |
| Mar 31, 2022 | 12.63 Bn |
| Dec 31, 2021 | 14.77 Bn |
| Sep 30, 2021 | 13.99 Bn |
| Jun 30, 2021 | 13.93 Bn |
| Mar 31, 2021 | 13.28 Bn |
| Dec 31, 2020 | 16.00 Bn |
| Sep 30, 2020 | 30.93 Bn |
| Jun 30, 2020 | 24.64 Bn |
| Mar 31, 2020 | 26.95 Bn |
| Dec 31, 2019 | 30.30 Bn |
| Sep 30, 2019 | 28.36 Bn |
| Jun 30, 2019 | 33.73 Bn |
| Mar 31, 2019 | 34.02 Bn |
| Dec 31, 2018 | 35.84 Bn |
| Sep 30, 2018 | 34.92 Bn |
| Jun 30, 2018 | 32.73 Bn |
| Mar 31, 2018 | 30.26 Bn |
| Dec 31, 2017 | 31.82 Bn |
| Sep 30, 2017 | 35.32 Bn |
| Jun 30, 2017 | 28.59 Bn |
| Mar 31, 2017 | 21.42 Bn |
| Dec 31, 2016 | 19.59 Bn |
| Sep 30, 2016 | 21.43 Bn |
| Jun 30, 2016 | 18.35 Bn |
| Mar 31, 2016 | 19.27 Bn |
| Dec 31, 2015 | 24.76 Bn |
| Sep 30, 2015 | 25.91 Bn |
| Jun 30, 2015 | 18.09 Bn |
| Mar 31, 2015 | 20.06 Bn |
| Dec 31, 2014 | 17.71 Bn |
| Sep 30, 2014 | 12.56 Bn |
| Jun 30, 2014 | 15.50 Bn |
| Mar 31, 2014 | 12.97 Bn |
| Dec 31, 2013 | 7.00 Bn |
| Sep 30, 2013 | 6.97 Bn |
| Jun 30, 2013 | 7.07 Bn |
| Mar 31, 2013 | 6.66 Bn |
| Dec 31, 2012 | 6.16 Bn |
| Sep 30, 2012 | 5.88 Bn |
| Jun 30, 2012 | 5.84 Bn |
| Mar 31, 2012 | 5.83 Bn |
| Dec 31, 2011 | 13.92 Bn |
| Sep 30, 2011 | 6.15 Bn |
| Jun 30, 2011 | 6.22 Bn |
| Mar 31, 2011 | 6.85 Bn |
| Dec 31, 2010 | 5.71 Bn |
| Sep 30, 2010 | 6.03 Bn |
| Mar 31, 2010 | 5.12 Bn |
| Dec 31, 2009 | 4.81 Bn |
| Sep 30, 2009 | 4.30 Bn |
| Jun 30, 2009 | 4.00 Bn |